U.S. Supreme Court to Review FDA's Rejection of Flavored Vape PMTAs

Nov.26.2024
U.S. Supreme Court to Review FDA's Rejection of Flavored Vape PMTAs
The U.S. Supreme Court will hear a case regarding FDA's rejection of PMTAs for flavored vape products from two companies. Lower courts previously ruled that FDA did not follow proper legal procedures when rejecting the applications. The Supreme Court plans to hear the case in its upcoming term.

According to a report by Tobacco Reporter on November 25th, the US Supreme Court will next week hear arguments from the Food and Drug Administration (FDA) regarding the rejection of pre-market tobacco product applications (PMTA) from two companies. These companies wish to sell flavored vape products that are considered to pose health risks to young consumers.

 

Previously, a lower court ruled that FDA did not follow proper legal procedures under federal law when rejecting the applications of these two companies to market their nicotine products. The Supreme Court has decided to hear FDA's appeal and plans to hear the case in the next session, which begins in October.

 

Two e-cigarette liquid manufacturers, Triton Distribution and Vapetasia, submitted pre-market tobacco product applications in 2020, which included flavors such as sour grape, pink lemonade, and caramel pudding. The products had names like "Jimmy The Juice Man Strawberry Astronaut" and "Suicide Bunny Bunny Season." FDA rejected the applications from these two companies and over a million other products.

 

In 2021, Triton and Vapetasia applied for a review of the FDA's rejection decision with the United States Fifth Circuit Court of Appeals in New Orleans. In January of this year, the Fifth Circuit Court of Appeals ruled that FDA was too arbitrary in its denial of the application and did not consider the companies' plans to prevent minors from accessing and using their products.

 

Russian lawmaker warns against premature implementation of warning images on heated tobacco packaging, citing ongoing EAEU regulations discussions
Russian lawmaker warns against premature implementation of warning images on heated tobacco packaging, citing ongoing EAEU regulations discussions
Russian lawmakers are debating whether to place warning images on heated tobacco packaging to deter youth usage.
Aug.08 by 2FIRSTS.ai
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Singapore Shuts Down Over 600 Telegram Groups to Crack Down on Illegal E-Cigarette Sales
Since April 2024, Singapore’s Health Sciences Authority (HSA) has shut down over 600 Telegram groups promoting or selling e-cigarettes and Kpods. This is the first time HSA has released such data. Additionally, from January 2024 to March 2025, HSA and the Ministry of Health removed more than 6,800 online listings related to e-cigarettes—more than double the number removed in 2023.
Jul.17 by 2FIRSTS.ai
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
British American Tobacco (BAT) plans to pilot sales of its disposable synthetic nicotine vape, Vuse One, in the United States, with launches expected in South Carolina, Florida, and Georgia in late September. The product has not yet received approval from the U.S. Food and Drug Administration (FDA). According to Reuters, this move marks a major shift in BAT’s stance after years of opposing the sale of unauthorized vapes. The company said the product will be distributed through major national ret
Aug.21 by 2FIRSTS.ai
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Lead: Spain's proposed e-cigarette and nicotine pouch restrictions face strong opposition from seven EU countries and the European Commission.
Aug.21 by 2FIRSTS.ai
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
U.S. FDA to Review Philip Morris International’s IQOS Risk Modification Renewal Application in October
The U.S. FDA will review Philip Morris International’s renewal application for five IQOS products' modified risk status at an October 7 TPSAC meeting, evaluating whether they still meet the required standards.
Jul.30 by 2FIRSTS.ai
Retraction Statement Regarding the Article: “2Firsts Investigation | U.S. Tightens E-Cigarette Enforcement, Disrupting China Air Shipments — Industry Estimates $78 Million in Goods Seized in Six Months”
Retraction Statement Regarding the Article: “2Firsts Investigation | U.S. Tightens E-Cigarette Enforcement, Disrupting China Air Shipments — Industry Estimates $78 Million in Goods Seized in Six Months”
Retraction Statement.
Jul.15